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Abstract
Background:  Paroxysmal extreme pain disorder (PEPD) is an autosomal dominant painful
neuropathy with many, but not all, cases linked to gain-of-function mutations in SCN9A which
encodes voltage-gated sodium channel Nav1.7. Severe pain episodes and skin flushing start in
infancy and are induced by perianal probing or bowl movement, and pain progresses to ocular and
mandibular areas with age. Carbamazepine has been effective in relieving symptoms, while other
drugs including other anti-epileptics are less effective.
Results: Sequencing of SCN9A coding exons from an English patient, diagnosed with PEPD, has
identified a methionine 1627 to lysine (M1627K) substitution in the linker joining segments S4 and
S5 in domain IV. We confirm that M1627K depolarizes the voltage-dependence of fast-inactivation
without substantially altering activation or slow-inactivation, and inactivates from the open state
with slower kinetics. We show here that M1627K does not alter development of closed-state
inactivation, and that M1627K channels recover from fast-inactivation faster than wild type
channels, and produce larger currents in response to a slow ramp stimulus. Using current-clamp
recordings, we also show that the M1627K mutant channel reduces the threshold for single action
potentials in DRG neurons and increases the number of action potentials in response to graded
stimuli.
Conclusion: M1627K mutation was previously identified in a sporadic case of PEPD from France,
and we now report it in an English family. We confirm the initial characterization of mutant M1627K
effect on fast-inactivation of Nav1.7 and extend the analysis to other gating properties of the
channel. We also show that M1627K mutant channels render DRG neurons hyperexcitable. Our
new data provide a link between altered channel biophysics and pain in PEPD patients.
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Background
Recent genetic studies have identified sodium channel
Nav1.7 as a major contributor to pain [1,2]. Nav1.7 is pre-
dominantly expressed in dorsal root ganglion (DRG) and
sympathetic ganglion neurons [3-6], and specifically in
most functionally-identified DRG nociceptive neurons
[7]. Global knock-out of Nav1.7 in mice is neonatal lethal
while nociceptor-specific knock-out results in elevated
mechanical and thermal pain thresholds and an attenu-
ated pain response [8]. Surprisingly, congenital loss of
Nav1.7 in humans is not associated with cognitive or
motor deficits, but causes complete indifference to pain
[9-11]. In contrast, one set of gain-of-function mutations
of Nav1.7 in inherited erythromelalgia (IEM) leads to
severe episodes of pain, mostly in the feet and hands [12-
18], and a different set of mutations results in paroxysmal
extreme pain disorder (PEPD) [19]. Because some cases of
PEPD do not carry mutations in Nav1.7 [19], it is impor-
tant to genetically profile new PEPD cases to determine
the molecular basis of the disease which may influence
possible therapy options.
Severe pain in PEPD patients accompanied by redness in
the lower body can start in infancy, is induced by bowel
movement or probing of perianal areas, and can be
accompanied by tonic nonepileptic seizures, syncopes,
bradycardia and occasionally asystole [20]. The cause for
the seizures and cardiac symptoms is not well understood.
Pain progresses with age to affect ocular and maxillary/
mandibular areas and is triggered by cold, eating or emo-
tional state [20]. Pain episodes can last seconds to min-
utes (and hours in extreme cases), and gradually subside.
Whole-cell voltage-clamp studies have shown that all of
the IEM mutations lower the voltage threshold for Nav1.7
activation, with most mutations increasing the ramp
response of the channel [13,16,17,21-25]. In contrast,
PEPD mutations in Nav1.7 impair fast-inactivation and
can result in a persistent current [19]. The M1627K muta-
tion, which is located in domain IV S4–S5 linker (DIV/
S4–S5) and first identified in a sporadic case of PEPD
from France, has been shown to cause a significant shift in
the voltage-dependence of steady-state fast-inactivation of
mutant channels but does not produce a persistent current
[19]. The effects of M1627K on other properties that influ-
ence channel function, for example slow-inactivation,
recovery from fast-inactivation, and responses to ramp
stimuli, have not been reported. Also, while it is predicted
that impaired fast-inactivation could be linked to repeti-
tive firing in hyperexcitable DRG neurons [26], the effects
of the PEPD mutation on DRG neuron excitability have
not been experimentally demonstrated.
We report here the identification of M1627K mutation in
a new family with PEPD. We confirm that the M1627K
mutation causes a large depolarized shift in fast-inactiva-
tion without altering channel activation, and show that
mutant channels inactivate from the open state with
slower kinetics, but without altering the rate for develop-
ment of closed-state inactivation. We demonstrate that
M1627K channels recover from fast-inactivation faster
than wild type (WT) channels, and produce larger currents
in response to a ramp stimulus. We also show, for the first
time, that a PEPD mutation reduces the threshold for sin-
gle action potentials and increases the number of action
potentials in DRG neurons in response to graded stimuli,
providing a link between altered channel biophysics and
the pain that occurs in PEPD.
Results
Clinical phenotype
An English family with a history of PEPD in two genera-
tions was evaluated for a linkage with mutations in
SCN9A. The proband is a 36 year old Caucasian female
who presented to her physician with a lifelong history of
episodic erythema and painful burning sensations from
the waist downward. The episodes of erythema and
extreme pain last for approximately 20 minutes. Her
symptoms began in infancy and occurred several times a
year, with pain triggered by bowel movement, passage of
flatus or any painful stimulus in the lower half of her
body. The patient experienced two attacks during each of
her two deliveries, each of which occurred by Caesarian
section under general anesthesia. Treatment with car-
bamazepine was initiated in infancy and currently has
been successful in reducing her attacks to approximately
one per year. As a teenager, the patient tried to reduce the
daily dose; however, at 400 mg of carbamazepine per day
she experienced an increase in the frequency of her
attacks. Her symptoms dramatically improved upon
returning to the original dose of 600 mg per day. Based on
the clinical evaluation, the patient was diagnosed with
PEPD.
The proband's father and sister have a similar presenta-
tion of the disease since infancy. The father is currently
not treated with any medication and feels that the fre-
quency of attacks has increased with age. The proband's
sister has been treated effectively with carbamazepine
since childhood, but requires a lower dose of 200 mg/day.
Prior to starting carbamazepine at one year of age, she had
frequent episodes of pain and erythema from the waist
downward. She self-reports that her symptoms have
improved with age, and currently she has suffered just two
attacks in the last five years. Unlike the proband, she can
recall three attacks in her arms triggered by minor hand
injuries. She also had two attacks during Caesarian section
under general anesthesia.Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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Identification of M1627K mutation
Genomic DNA from the proband and her family (Figure
1A) was used to amplify all known exons of SCN9A, and
their sequences were compared to the reference Nav1.7
cDNA [27]. Proband and control templates produced sim-
ilar amplicons which were purified and sequenced.
Sequence analysis identified a T to A in exon 26 (Figure
1B), corresponding to position 4879 of the reference
sequence [27]. This mutation substitutes methionine (M)
by lysine (K) at position 1627 of the polypeptide, which
is located in the middle of the DIV/S4–5 linker. The mis-
sense mutation segregates with the disease in this family,
with the affected father and a sister heterozygotes for the
mutation and an unaffected brother carrying only the
wild-type alleles (Figure 1A). M1627 is conserved in all
human sodium channels (Figure 1C), and was previously
identified independently in a sporadic case of PEPD from
France [19].
Voltage-clamp electrophysiology: activation and 
deactivation
Sodium currents from WT hNav1.7R, and the mutant
channel M1627K were recorded from stably transfected
HEK 293 cells in order to study the effects of this mutation
on gating properties of the channel. Figure 2 shows repre-
sentative WT (Figure 2A) and M1627K (Figure 2B) whole-
cell currents elicited with a series of depolarizing test
pulses from a holding potential of -100 mV. Although the
peak current amplitude was smaller for M1627K channels
(1.3 ± 0.2 nA, n = 15) than for WT channels (4.2 ± 0.7 nA,
n = 12), the peak current-voltage relationship was similar
for WT and M1627K channels (Figure 3A). The midpoint
of activation (estimated by fitting the data with a Boltz-
man function) was -25.4 ± 1.0 mV (n = 14) for M1627K
currents and -22.5 ± 1.9 mV (n = 11) for WT currents (p >
0.05). The kinetics of deactivation, which reflect the tran-
sition from the open to the closed state, of WT and
M1627K channels were also examined by eliciting tail cur-
rents at a range of potentials after briefly activating the
channels (at -20 mV for 0.5 ms). The time constants for
deactivation were not altered at potentials ranging from -
100 mV to -40 mV for the M1627K channel (Figure 3B).
Together these data confirm that the M1627K mutation
does not alter Nav1.7 activation properties.
Voltage-clamp electrophysiology: inactivation
We next examined the effects of the M1627K mutation on
inactivation properties. The voltage-dependence of
steady-state fast-inactivation was dramatically shifted in
the depolarizing direction by the M1627K mutation (Fig-
ure 3C). The midpoint of fast-inactivation (V1/2, measured
with 500 ms pre-pulses) was -75.3 ± 1.7 mV for WT (n =
11) and -56.0 ± 1.4 mV for M1627K (n = 15) channels.
The slope of the steady-state inactivation relationship was
6.2 ± 0.1 mV/e-fold for WT channels and 9.3 ± 0.6 mV/e-
fold for M1627K channels. Differences in the V1/2 and
slope of fast-inactivation fit were significant (p < 0.001).
However, the fraction of current remaining available after
the -10 mV inactivation prepulse was not significantly dif-
ferent (p > 0.05) between WT (1.3 ± 0.3%) and M1627K
(1.9 ± 0.5%) channels.
By contrast, the voltage-dependence of slow-inactivation
of hNav1.7R  currents was only slightly altered by the
M1627K mutation (Figure 3D). Ten second pre-pulses,
followed by 100 ms recovery pulses to -120 mV to allow
recovery from fast-inactivation, preceded the test pulse (to
0 mV for 20 ms) to determine the fraction of current avail-
able. The M1627K mutation reduced the fraction of slow-
inactivated mutant channels that occurred at -80, -70 and
-60 mV, which might contribute to increased channel
availability at normal resting membrane potentials.
It should be noted that in this study we used 500 ms inac-
tivating prepulses to determine the voltage-dependence of
steady-state fast-inactivation. The time-constant for devel-
opment of fast-inactivation at -70 mV is ~140 ms for WT
channels [28] and therefore a 500 ms prepulse, which
allows ~97% of the channels to inactivate at -70 mV, is
ideal for measuring the voltage-dependence of steady-
state fast-inactivation. One concern is that 500 ms could
allow channels to also enter a state of slow-inactivation.
Our data does not support this conclusion because 1) the
time constant for development of slow-inactivation of WT
channels at -50 mV was greater than 1000 ms and 2) accu-
mulation of channels in a slow-inactivated state after 500
ms at -50 mV was less than 10% [29]. To further investi-
gate this issue, we compared the voltage-dependence of
WT and M1672K channel fast-inactivation using 100 ms
prepulses (Figure 4). Although the inactivation curve for
WT channels was more depolarized with the 100 ms pre-
pulse than the 500 ms prepulse (due to incomplete fast-
inactivation at negative potentials) the inactivation curves
for M1672K channels were nearly identical (Figure 4).
These data support the conclusion that the M1672K muta-
tion causes a depolarizing shift in the voltage-dependence
of fast-inactivation.
Mutant channels exhibited slower decay kinetics (Figure
2) compared to WT channels, and we observed significant
differences in the time constants for current inactivation
between WT and M1627K channels. The rate of open-state
inactivation was quantified by fitting the decay phase of
the macroscopic current with a single exponential func-
tion. The time constants estimated from these fits are plot-
ted as a function of the test potentials (Figure 5A). The
time constants were much larger for M1627K currents
than for WT currents over voltages that range from -30 to
+40 mV. At -30 mV, for example, WT currents inactivated
with a time constant of 5.8 ± 0.8 ms (n = 6) and M1627KMolecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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Inheritance pattern of the M1627K mutation in DIV/S4–5 linker in Nav1.7 in familial PEPD Figure 1
Inheritance pattern of the M1627K mutation in DIV/S4–5 linker in Nav1.7 in familial PEPD. A, Inheritance of PEPD 
in two generations of a family with PEPD from the UK. Circles denote females; squares denote males, and symbols with diago-
nal line denote deceased individuals. The proband is indicated by an arrow. Blackened symbols indicate subjects affected with 
PEPD. B, Sequence traces of a segment of exon 26 in the region which encodes M1627. Left trace shows homozygous T4879 
from exon 26 of the unaffected brother of the proband. Right trace shows heterozygous T4879A in exon 26 from the proband. 
This missense mutation leads to M1627K substitution. In (A), a (+) symbol denotes subjects heterozygous for the T4879A 
mutation in exon 26, and a (-) symbol denotes subjects without the mutation. Inheritance of PEPD segregates with the T4879A 
heterozygosity. C, Sequence alignment of DIV/S4–S5 linker from human sodium channels. The M1627K substitution in this fam-
ily with PEPD is noted in the sequence from Nav1.7. The M1476I from a family with cold-induced myotonia occurs at the cor-
responding site as M1627 in Nav1.4. The M1652R from a family with LQT-3 occurs at the adjacent methionine residue in 
Nav1.5 (M1628 in Nav1.7).Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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currents inactivated with a time constant of 9.9 ± 1.3 ms
(n = 6). At +25 mV, WT currents inactivated with a time
constant of 0.44 ± 0.01 ms (n = 6) and M1627K currents
inactivated with a time constant ten times larger (4.9 ± 0.4
ms, n = 6). These differences were statistically significant
(p < 0.05). We also examined the development of closed-
state inactivation at voltages ranging from -90 to -50 mV
(Figure 5A, triangular symbols). Cells were stepped to the
inactivation potential (from a holding potential of -100
mV) for increasing durations, and then stepped to the test
potential (0 mV) to measure the fraction of the remaining
available channels. The data from these cells were fitted
with a single exponential function. Interestingly, the time
course for the development of inactivation from the
closed state was not significantly altered by the M1627K
mutation, indicating that the M1627K mutation has a
greater effect on open-state inactivation than closed-state
inactivation.
Voltage-clamp electrophysiology: recovery from fast-
inactivation
The time course for recovery from fast-inactivation (rep-
riming) of WT and M1627K channels was measured at
recovery voltages ranging from -140 to -60 mV. Fast-inac-
tivation was induced with 20 ms inactivating prepulses to
-20 mV. The time course for recovery from inactivation for
both WT and M1627K currents could be fitted with single
exponential functions. Recovery from inactivation was
significantly faster for M1627K channels than for WT
channels (Figure 5B). For example, the time constant for
recovery of WT channels (τ = 92 ± 11 ms, n = 7) was
almost 4-fold larger at -70 mV than the corresponding
time constant for M1627K channels (τ = 26 ± 3 ms, n = 7).
Voltage-clamp electrophysiology: response to a ramp 
stimulus
IEM mutations are known to produce enhanced responses
to small, slow depolarizations (ramp stimuli) [1], but the
ramp response has not been studied in PEPD mutations
[19]. Figure 6A shows the ramp current recorded from a
M1627K cell producing a current with peak amplitude of
2.8 nA, compared to the ramp current recorded from a WT
cell producing a comparable current with a peak ampli-
tude of 3.4 nA. The ramp currents elicited with slow ramp
(0.2 mV/ms) depolarizations from -100 to +20 mV were
expressed as a percentage of peak current (Figure 6B) and
the relative amplitude of the ramp currents were signifi-
cantly larger for M1627K channels (7.0 ± 1.0%; n = 9)
than for WT channels (1.0 ± 0.2%; n = 7). We compared
the relative amplitude of the ramp currents with the extent
of overlap between the voltage-dependence of activation
and steady-state fast-inactivation (Figure 6C). As shown,
the relative amplitude of the WT and M1627K ramp cur-
rents, and the voltage-dependence of these currents, corre-
lates reasonably well with the respective overlap between
the voltage-dependence of activation and steady-state fast-
inactivation.
Current Clamp electrophysiology
Previous studies have not examined the effect of PEPD
mutations on DRG neuron excitability [19]. We assessed
the effect of the M1627K mutation on DRG neuron excit-
ability by recording in current-clamp mode from DRG
neurons transfected with GFP and either WT or the
M1627K mutant construct. The GFP-positive cells that
were selected for recording were similar for the two groups
in cell size, as measured either by apparent cell body
diameter (24.1 ± 0.6 μm for M1627K vs. 25.5 ± 0.5 μm for
WT) or by measured whole-cell capacitance (23.4 ± 1.5 pF
for M1627K vs. 23.6 ± 1.4 pF for WT). The expression of
the M1627K mutant channels caused a significant reduc-
tion in the threshold to generate action potentials. DRG
neurons (n = 28) that express WT channels required on
average about 300 pA to reach threshold (292 ± 37 pA),
whereas DRG neurons that express the M1627K mutant
channel (n = 31) only required, on average, about half the
amount of current to reach threshold (154 ± 20 pA; p <
0.005). One possibility for the reduction in threshold is
an increase in input resistance that would give a larger
M1627K currents decay slower than WT Nav1.7 currents Figure 2
M1627K currents decay slower than WT Nav1.7 cur-
rents. Representative WT (A) and M1627K (B) Nav1.7 cur-
rents are shown. Cells were held at -100 mV and currents 
were elicited with 50 ms test pulses to potentials ranging 
from -80 to 40 mV. For better comparison, WT and M1627K 
currents elicited with -30 mV (C) and +25 mV (D) depolari-
zations are shown superimposed. Although the rate of activa-
tion is not apparently altered, the decay phase is substantially 
faster for WT currents.Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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depolarization to a fixed stimulus current. However, the
difference of the input resistance between the two groups
of transfected cells did not reach statistical significance
(M1627K: 795 ± 105 MΩ; WT: 662 ± 67 MΩ; p = 0.3). A
similar small, but non-significant, difference had been
reported for the A863P IEM mutant [17].
No significant difference in resting membrane potential
(RMP) was observed between the two groups of cells
(M1627K: -60.1 ± 1.2 mV; WT: -60.1 ± 1.6 mV; p = 0.97).
Additionally, the amplitude of action potential elicited at
threshold showed no significant differences between
M1627K transfected DRG neurons (n = 31) compared to
The M1627K mutation alters inactivation properties of Nav1.7 Figure 3
The M1627K mutation alters inactivation properties of Nav1.7. A, Normalized peak current-voltage relationship for 
WT (filled squares, n = 11) and M1627K (open circles, n = 15) channels. Cells were held at -100 mV and currents were elicited 
with 50 ms test pulses to potentials ranging from -80 to 40 mV. B, Time constants for tail current deactivation at repolarization 
potentials ranging from -40 to -100 mV for WT (filled squares, n = 8) and M1627K (open circles, n = 9) Nav1.7 channels. Time 
constants were obtained with single exponential fits to the deactivation phase of the currents. C, Comparison of steady-state 
fast-inactivation for WT (filled squares, n = 11) and M1627K (open circles, n = 15) Nav1.7 channels. Currents were elicited 
with test pulses to 0 mV following 500 ms inactivating prepulses. D, Comparison of slow-inactivation for WT (filled squares, n 
= 3) and M1627K (open circles, n = 4) Nav1.7 channels. Slow inactivation was induced with 10 s prepulses, followed by 100 ms 
pulses to -120 mV to allow recovery from fast-inactivation. A test pulse to 0 mV for 20 ms was used to determine the fraction 
of current available.Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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WT transfected DRG neurons (n = 28) for peak (M1627K:
60.3 ± 2.2 mV, WT: 54.8 ± 2.9 mV, Mann-Whitney rank
sum test, p = 0.24) or for after-hyperpolarization
(M1627K: -64.2 ± 1.3 mV, WT: -59.2 ± 1.8 mV, t-test, p =
0.07).
DRG neurons that express the M1627K mutant channels
fired more action potentials in response to suprathreshold
graded stimuli compared to neurons that express WT
channels. When the number of spikes elicited by a series
of 1-second long depolarizing current injections was
quantified, it is clear that on average the M1627K trans-
fected cells responded with more spikes over the entire
current injection range compared to WT transfected cells
(Figure 7). The difference in firing was significantly differ-
ent (p < 0.05) for the current injections between 200 pA
to 750 pA. Since the threshold value for the M1627K
mutant was significantly lower than for WT channel, one
possible explanation would be that we are not comparing
cells at the equivalent rheobase. Therefore, we carried out
further analysis to compare these two groups as a function
of fold-threshold. This analysis clearly demonstrated that
the M1627K mutant causes increased excitability, reach-
ing significance for 3× threshold as well for the maximum
response that could be evoked (Figure 8).
Higher rates of firing appeared to occur in M1627K cells
with the lowest threshold values, which often did not
reach their maximum firing rate until current injections of
>10× threshold. In contrast, most of the WT transfected
cells only produced a maximum of 1 or 2 action potentials
even for current injections exceeding 1 nA (but still less
than 4× threshold). Examples of these firing phenotypes
are shown in Figure 9. The responses from a cell trans-
fected with the M1627K mutant sodium channel in this
case had a threshold of only 25 pA and reached a maxi-
mum response of 18 impulses/second to a current injec-
tion of only 350 pA. In contrast, this example of a WT
transfected cell had threshold of 450 pA and fired a maxi-
mum of 2 spikes in response to a current injection of 1200
pA.
Discussion
In this study, we identified a mutation, M1627K, in
Nav1.7 from a previously unreported family with PEPD.
Life-long symptoms in two members of the family are
controlled by the sodium channel blocker car-
bamazepine. We investigated the functional effect of the
M1627K substitution on Nav1.7, and confirm that it
causes a large depolarizing shift in the voltage-depend-
ence of steady-state fast-inactivation, with no effect on
channel activation. Using current clamp, we show that
M1627K mutant channels lower threshold for single
action potentials and increase the number of action
potentials in response to graded suprathreshold stimuli in
small DRG neurons, most of which are nociceptors. Thus
we show, for the first time, that a PEPD mutation pro-
duces nociceptor hyperexcitability.
Missense mutations in Nav1.7 have been linked to two
types of inherited painful neuropathies, early-onset IEM
[12-18], and PEPD [19]. While missense mutations in
Nav1.7 have been found in most families with IEM and
PEPD in whom the gene was sequenced, both IEM and
PEPD may be genetically heterogenous because muta-
tions in the coding exons of SCN9A were not found in 5
cases of PEPD [19], or in cases of familial early-onset [30]
and adult-onset IEM [31], suggesting that other target
genes or mutations in non-coding regions of SCN9A
might underlie these cases. Mutations in the coding exons
of sensory neuron-specific sodium channels Nav1.8 and
Nav1.9 have been ruled out as causative in these cases of
inherited erythromelalgia [30]. We present in this study a
previously unreported familial case of PEPD from the UK
with the mutation M1627K, in the DIV/S4–S5 linker,
which is also present in a sporadic case of a male patient
from France [19,20].
The patients in our study have responded favorably to
treatment with carbamazepine, similar to those reported
previously [20]. Carbamazepine targets voltage-gated
Effect of prepulse duration on voltage-dependence of inacti- vation Figure 4
Effect of prepulse duration on voltage-dependence of 
inactivation. A, Comparison of steady-state fast-inactiva-
tion for WT (squares, n = 3) and M1627K (circles, n = 4) 
Nav1.7 channels. Currents were elicited with test pulses to 0 
mV following either 100 ms (filled symbols) or 500 ms 
(unfilled symbols) inactivating prepulses. The apparent volt-
age-dependence of inactivation of WT Nav1.7 channels is 
altered by the prepulse duration. In contrast the apparent 
voltage-dependence of inactivation of M1627K mutant chan-
nels is not significantly altered by changing the prepulse dura-
tion from 100 to 500 ms. Data are presented as mean ± S.E.Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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sodium channels [32] and potently inhibits TTX-S chan-
nels in DRG neurons [33], including those specifically
produced by wild-type Nav1.7 channels [34]. Although we
did not examine the sensitivity of M1672K channels to
carbamazepine in this study, carbamazepine has been
shown to block persistent currents generated by I1461T
and T1464I PEPD Nav1.7 mutant channels [19], and it is
likely that inhibition of M1672K channel activity contrib-
utes to the therapeutic action of carbamazepine in the two
patients examined in our study.
Our observations of a 19 mV depolarizing shift in the volt-
age-dependence of fast-inactivation for M1627K confirm
the linkage of impaired fast-inactivation of Nav1.7 and
PEPD reported by Fertleman et al [19]. We report here that
recovery from fast-inactivation was accelerated in the
M1627K, consistent with a destabilized inactivation state
of the channel. We have also observed that M1627K dis-
play an increased ramp current, similar to IEM mutations
[13,16,17,21-25]. M1627K displayed a trend toward a
small (< 3 mV) hyperpolarizing shift in activation, but
this was not statistically significant. Depolarizing shifts in
fast-inactivation have also been observed in some
[13,16,17] but not all [21-25] mutations that cause IEM.
However, the depolarizing shifts in fast-inactivation asso-
ciated to date with IEM (= 10 mV) are smaller than the
shifts in PEPD mutations ([19] and this study). It is
intriguing that the IEM mutation A863P with a +10 mV
depolarizing shift in fast-inactivation [13,16,17] does not
yield symptoms of PEPD, suggesting that other factors,
perhaps genetic makeup or bigger shifts in the voltage-
dependence of fast-inactivation may contribute to clinical
manifestations of the disease.
Gating properties of Nav1.7, for example slow recovery
from fast-inactivation and an ability to respond to ramp
stimuli [28,35], suggest that, normally, it may act as a
"threshold" channel which boosts subthreshold stimuli,
and thus sets the gain in nociceptors [36,37]. Therefore, it
is not surprising that mutations lowering the voltage-
threshold for channel activation as in IEM lead to DRG
neuron firing in response to a weaker stimulus that may
normally be innocuous. Mutations that impair fast-inacti-
vation as in PEPD allow more current to pass through the
mutant channel, and thus induce stronger depolarization
that brings the DRG neuron closer to the voltage-thresh-
old for all-or-none action potential firing. By analogy to
mutations in the cardiac channel Nav1.5 which cause
The M1627K mutation alters rate of open-state inactivation and recovery from inactivation properties of Nav1.7 Figure 5
The M1627K mutation alters rate of open-state inactivation and recovery from inactivation properties of 
Nav1.7. A, Time constants for development of fast-inactivation as a function of voltage for WT (filled symbols, n = 6) and 
M1627K (open symbols, n = 6) Nav1.7 channels are shown. Open-channel inactivation time constants were measured at volt-
ages ranging from -45 to +40 mV by fitting the decay phase of currents elicited with depolarizing pulses with single exponen-
tials. The time constants for development of closed-state inactivation were estimated from single exponential fits to time 
courses measured at inactivation potentials ranging from -90 to -50 mV for WT (filled triangles, n = 6) and with M1627K (open 
triangles, n = 6) Nav1.7 channels. B, Recovery from inactivation kinetics are faster for M1627K mutant channels (open circles, 
n = 7) than for WT Nav1.7 channels (filled squares, n = 7). Time constants were estimated from single exponential fits to time 
courses measured at recovery potentials ranging from -140 to -60 mV. The recovery from inactivation voltage protocol 
involved prepulsing the cell to -20 mV for 20 ms to inactivate all of the current, then stepping the membrane potential back to 
the recovery potential for increasing recovery durations prior to the test pulse to 0 mV. The maximum pulse rate was 0.5 Hz.Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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The M1627K mutation increases the amplitude of currents elicited by slow ramp depolarizations Figure 6
The M1627K mutation increases the amplitude of currents elicited by slow ramp depolarizations. A, Represent-
ative ramp currents elicited by 600 ms long ramp depolarizations from -100 to +20 mV are shown recorded from a HEK293 
cell expressing WT channels (black trace) and from one expressing M1627K channels (red trace). The peak transient current 
amplitude elicited in the WT cell was larger (3.4 nA) than that of the M1627K cell (2.8 nA). B, The average relative ramp cur-
rent (ramp current divided by peak transient current amplitude) is larger for M1627K cells (red trace, n = 9) than for WT cells 
(black trace, n = 7). C, The properties of the averaged ramp currents are compared to the overlap between the voltage-
dependence of activation (derived from the current-voltage relationship) and steady-state fast inactivation. The inverted ampli-
tude of the WT ramp current was scaled so that it corresponded to the peak overlap between WT activation and steady-state 
fast inactivation (black shaded area). As can be seen, voltage-dependence of the WT ramp current corresponds to the region 
of overlap. Furthermore, the relative amplitude and voltage-dependence of the M1627K ramp currents corresponds to the 
overlap between M1627K activation and steady-state fast inactivation (red shaded area).Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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arrhythmias and in neuronal channel Nav1.1 which
causes epilepsy [26], the M1627K PEPD mutation which
impairs fast-inactivation of Nav1.7 would be expected to
increase repetitive firing, leading to hyperexcitablity of
DRG neurons.
Indeed, we now show in this study that a PEPD mutation
in human Nav1.7 channels in DRG neurons renders these
cells hyperexcitable. Current clamp recordings showed a
lower threshold for single action potentials, and an
increased firing rate in response to suprathreshold stimuli,
but did not show a change in resting membrane potential
for DRG neurons expressing M1627K channels. However,
Harty et al [13,16,17] have shown that depolarization of
RMP produced by an IEM mutation (A863P) contributes
to, but is not solely responsible for, the increase in DRG
neuron hyperexcitability produced by that mutation.
Thus, impaired fast-inactivation, accelerated repriming,
and the enhanced response to slow depolarizations may
all have contributed to the hyperexcitability of DRG neu-
rons expressing M1627K.
The DIV/S4–5 linker is highly conserved in length and
sequence (Figure 1C) among all sodium channels
described to date, suggesting an important role in the nor-
mal functioning of the channel. Increasing the length of
DIV/S4–S5 linker in Nav1.4 channels renders the mutant
channels non-functional [38]. Importantly, mutations in
this linker in several channels underlie pathological con-
ditions [19,38-44]. Interestingly, substitution of the first
methionine (Ma) in this linker (Figure 1C) with a posi-
tively charged residue (M1627K) in Nav1.7 causes PEPD
([19] and this study), while substitution with a hydropho-
bic residue isoleucine (M1476I) in Nav1.4 causes cold-
induced myotonia [42]. Subsitution of the second
methionine (Mb) with a positively charged residue
(M1652R) in Nav1.5 causes LQT-3 syndrome [44]. All
three disorders are linked to hyperexcitability of the cell in
which they are expressed, irrespective if it is a neuron or a
myocyte. The similarity of the outcome suggests a com-
mon mechanism of action, consistent with a conserved
function of this linker in channel gating.
Site-directed mutagenesis studies have suggested that the
DIV/S4–5 linker contributes to the receptor for the fast-
inactivation tripeptide IFM in loop 3 (L3) which links DIII
and DIV [45-47]. Structural studies have shown that this
linker can acquire an α-helical structure [48] with several
residues including the MaMb (Figure 1C) forming a hydro-
M1627K mutant channels increase frequency of firing of  DRG neurons compared to WT Nav1.7 channels Figure 7
M1627K mutant channels increase frequency of firing 
of DRG neurons compared to WT Nav1.7 channels. 
The mean total number of action potentials (defined as 
spikes in membrane potential greater than 0 mV) for a cur-
rent injection pulse of 1 second duration is plotted as a func-
tion of stimulus current intensity. The responses of neurons 
expressing M1627K mutant channels (n = 31) was signifi-
cantly elevated over the responses of neurons expressing 
WT Nav1.7r channels (n = 28) for stimulus current injections 
exceeding 200 pA (p < 0.05).
Firing frequency is increased in current clamped DRG neu- rons expressing M1627K mutant channels when stimulus  intensities are compared at fold-threshold Figure 8
Firing frequency is increased in current clamped 
DRG neurons expressing M1627K mutant channels 
when stimulus intensities are compared at fold-
threshold. For each cell the firing frequency at 2× and 3× 
threshold was determined and then averaged. Since thresh-
old is lower for M1627K expressing neurons (154 ± 19 pA) 
compared to hNav1.7r-WT expressing neurons (292 ± 37 
pA), the mean stimulus intensity at 2× and 3× was similarly 
scaled (319 ± 40 pA for M1627K versus 617 ± 68 for WT at 
2× threshold; 483 ± 59 pA for M1627K versus 926 ± 101 pA 
for WT at 3× threshold). The firing frequency was signifi-
cantly different between M1627K and WT for 3× threshold 
and peak firing frequency (p < 0.05 and p < 0.01) The lowest 
stimulus intensity that elicited the peak firing frequency was 
not significantly different (545 ± 50 pA for M1627K versus 
564 ± 60 pA for WT).Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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phobic cluster that is important for inactivation, but indi-
cate that these residues do not interact directly with the
IFM motif [47,49,50]. Taken together, these studies sug-
gest a model of two antiparallel α-helices [48]; this struc-
ture positions MaMb to interact with Y1470Y1471 (numbers
according to Nav1.7) in L3. Substitution of the residues
that correspond to Ma ([19] and this study) or Mb [44] or
Y1470Y1471 residues destabilizes the inactivated state of the
channel and yields similar gating changes in several chan-
nels. Interestingly, phosphorylation by Fyn kinase of Y1495
which is predicted to interact with Ma in Nav1.5 (equiva-
lent to Y1471 in Nav1.7), produces a significant depolariz-
ing shift in the voltage-dependence but no effect on the
rate of steady-state fast-inactivation [51]. Thus the intro-
duction of a charged residue at either of these two sites
destabilizes this interaction and leads to impaired binding
of the inactivation gate with its receptor.
In summary, our results show that a PEPD mutation pro-
duces hyperexcitability in DRG neurons. Our findings
also confirm the impairment of fast-inactivation previ-
ously associated with PEPD mutations, but show that, in
addition, a PEPD mutation can enhance the response of
the Nav1.7 channel to small, slow depolarizations and
Representative traces illustrating the differences in action potential firing in DRG neurons expressing either WT or M1627K  channels Figure 9
Representative traces illustrating the differences in action potential firing in DRG neurons expressing either 
WT or M1627K channels. The upper panels are the responses of a DRG neuron expressing M1627K channels in which the 
threshold for action potential generation was 25 pA. Panel A: stimulus intensity was 50 pA (2× threshold); panel B: stimulus 
intensity was 75 pA (3× threshold); panel C: stimulus was 350 pA (14× threshold) at which the peak rate was recorded. The 
lower panels are the responses of a DRG neuron expressing WT Nav1.7 channels in which the threshold for action potential 
generation was 450 pA. Panel D: stimulus intensity was 900 pA (2× threshold); panel E: stimulus was 1400 pA (3× threshold); 
panel F: shows that the peak response for this cell occurred at 1200 pA.Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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accelerate repriming. These data contribute to a better
understanding of the pathophysiology of pain in patients
with PEPD and provide additional support for efforts to
develop Nav1.7-specific therapeutics for treatment of neu-
ropathic pain.
Materials and methods
Patients
The proband (Figure 1) is a 36 year old female with a his-
tory of erythema and burning pain in the lower parts of
the body. Family consent was obtained according to an
approved institutional review board protocol and blood
samples were then withdrawn and analyzed for mutations
in SCN9A.
Exon screening
Genomic DNA (gDNA) was purified from venous blood.
Human Caucasian variation panel DNA (25 males, 25
females; The Coriell Institute, Camden, NJ) was used as a
normal population control. Coding exons and flanking
intronic sequences were amplified and sequenced as
described previously [13]. Briefly, PCR amplification was
carried out using 150 ng gDNA, 1 μM primers and Expand
Long Template polymerase (Roche, Indianapolis, IN) in a
50 μl reaction volume for 35 cycles (95°C × 30 s, 55°C ×
30 s and 72°C × 1 min.). Short exons were amplified
using two primers, whereas exon 26 required four sets of
primers to cover its entirety. Genomic sequences were
compared to the reference Nav1.7 cDNA [27] to identify
sequence variation. Sequencing was performed at the
Howard Hughes Medical Institute/Keck Biotechnology
Center at Yale University. Sequence analysis used BLAST
(National Library of Medicine) and Lasergene (DNAStar,
Madison, WI).
Voltage-clamp electrophysiology
The plasmid carrying the TTX-resistant (TTX-R) version of
human Nav1.7 cDNA (hNav1.7R) was previously
described [35]. The M1627K mutation was introduced
into hNav1.7R  using QuickChange XL II site-directed
mutagenesis (Stratagene, La Jolla, CA). Transfected HEK
293 cells, grown under standard culture conditions (5%
CO2, 37°C) in Dulbeccos's Modified Eagle's Medium sup-
plemented with 10% fetal bovine serum, were treated
with G418 for several weeks, and stable cell lines that
express the mutant channel were selected.
Whole-cell patch-clamp recordings were conducted at
room temperature (~21°C) using an EPC-10 amplifier
and the Pulse program (v 8.5, HEKA Electronic, Ger-
many). Fire-polished electrodes (0.8–1.5 MΩ) were fabri-
cated from 1.7-mm VWR capillary glass using a Sutter P-
97 puller (Novato, CA). Average access resistance was 2.1
± 0.1 MΩ (mean ± SE, n = 27). Voltage errors were mini-
mized using ~40–75% series resistance compensation to
achieve identical (1.5 ± 0.2 mV) voltage error after series
resistance compensation for the two groups. Capacitance
artifacts were canceled using computer-controlled cir-
cuitry of the patch clamp amplifier and linear leak sub-
traction was used for all voltage clamp recordings.
Recordings were always started 3.5–4 minutes after estab-
lishing the whole-cell configuration. Membrane currents
were filtered at 5 kHz and sampled at 20 kHz. The pipette
solution contained (in mM): 140 CsF, 1 EGTA, 10 NaCl
and 10 HEPES (pH 7.3). The standard bathing solution
was (in mM) 140 NaCl, 3 KCl, 1 MgCl2, 1 CaCl2, and 10
HEPES (pH 7.3). Data were analyzed using Pulsefit
(HEKA Electronic, Germany) and Origin (Microcal Soft-
ware, Northampton, MA) software. Unless otherwise
noted, statistical significance was determined (p < 0.05)
using an unpaired t-test. Results are presented as mean ±
SEM and error bars in the figures represent standard errors
(SE).
Transfection of DRG neurons
The protocol for the care and sacrifice of rats used in the
study was approved by the Veterans Administration CT
Healthcare system IACUC. DRG tissue from 1- to 5-day
old Sprague Dawley rats were harvested and dissociated
using a protocol that was adapted from Rizzo et al [52].
Briefly, dissected ganglia were placed in ice cold oxygen-
ated complete saline solution (CSS), which contained (in
mM) 137 NaCl, 5.3 KCl, 1 MgCl2, 25 sorbitol, 3 CaCl2, 10
N-2-hydroxyethylpiperazine-N'  -2-ethanesulfonic acid
(HEPES); pH 7.2. They were then transferred to an oxy-
genated, 37°C CSS solution containing 1.5 mg/ml Colla-
genase A (Roche Applied Science, Indianapolis, IN) and
0.6 mM EDTA and incubated with gentle agitation at
37°C for 20 min. This solution was then exchanged with
an oxygenated, 37°C CSS solution containing 1.5 mg/ml
Collagenase D (Roche Applied Science, Indianapolis, IN),
0.6 mM EDTA and 30 U/ml papain (Worthington Bio-
chemical, Lakewood, NJ) and incubated with gentle agita-
tion at 37°C for 20 min. The solution was then aspirated
and the ganglia triturated in DRG media [(DMEM/Fl2
(1:1) with 100 U/ml penicillin, 0.1 mg/ml streptomycin
(Invitrogen, Carlsbad, CA) and 10% fetal calf serum
(Hyclone, Logan, UT)], which contained 1.5 mg/ml
bovine serum albumin (Sigma-Aldrich, St. Louis, MO)
and 1.5 mg/ml trypsin inhibitor (Roche Applied Science,
Indianapolis, IN).
Either WT hNav1.7R or M1627K mutant channels were
transiently transfected into the DRG neurons, along with
enhanced-GFP, by electroporation with a Nucleofector II
(Amaxa, Gaithersburg, MD) using Rat Neuron Nucleofec-
tor Solution and program G-013. The ratio of sodium
channel to GFP constructs was 5:1. Immediately after
transfection, the cells were allowed to recover for 5 min-
utes in Ca2+- and Mg2+-free culture medium (DMEM +
10% FBS). The cell suspension was then diluted with DRG
media containing 1.5 mg/ml bovine serum albumin andMolecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
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1.5 mg/ml trypsin inhibitor, 80 μl was plated on 12 mm
circular poly-D-lysine/laminin pre-coated coverslips (BD
Biosciences, Bedford, MA) and the cells incubated at 37°C
in 5% CO2 for 30 min. DRG media (1 ml/well), supple-
mented with 50 ng/ml each of mNGF (Alomone Labs,
Jerusalem, Israel) and GDNF (Peprotec, Rocky Hill, NJ),
was then added and the cells maintained at 37°C in a 5%
CO2 incubator for 18–48 hr before recording.
Current-clamp electrophysiology
Small (20–30 μm diameter) GFP-labeled DRG neurons
were used for current-clamp recording. Neurons with
round cell body morphology and clear processes were
selected for analysis and recordings were performed
between 20- and 50-hours post-transfection. Pipette
resistance was 1–3 MΩ when filled with the pipette solu-
tion which contained (in mM): 140 KCl, 0.5 EGTA, 5
HEPES, and 3 Mg-ATP, pH 7.3 with KOH (adjusted to 315
mOsm with dextrose). The extracellular solution con-
tained the following (in mM): 140 NaCl, 3 KCl, 2 MgCl2,
2 CaCl2, 10 HEPES, pH 7.3 with NaOH (adjusted to 320
mOsm with dextrose). Formation of a GΩ seal and the
transition to whole-cell configuration was performed in
voltage-clamp mode before proceeding to the current-
clamp recording mode. Recordings were obtained using
an Axopatch 200B amplifier (Molecular Devices, Sunny-
vale, CA) connected to a Digidata 1422 interface control-
led by Clampex software (Molecular Devices). Cells with
resting membrane potentials (RMP) more negative than -
40 mV that were stable (<10% variation during the first 5
minutes) were included for data analysis. Input resistance
was determined by fitting the slope of a line fit to hyper-
polarizing voltage responses to current steps of -5 pA to -
25 pA in 5 pA increments. Threshold was determined by
the first action potential elicited by a series of depolarizing
current injections that increased in 5 pA increments.
Action potentials were counted by detecting membrane
potential transients that exceeded the threshold value of 0
mV during 1-sec long depolarizing current injections.
Data are expressed as means ± SEM. Student's t-test was
used to assess the significance (p < 0.05) of differences
between parameters measured from DRG neurons trans-
fected with WT or M1627K mutant channels. Where indi-
cated, the Mann-Whitney rank sum test was applied
because of non-normal data distributions. Statistical anal-
ysis was performed using Sigmaplot software (Systat Soft-
ware, San Jose, CA).
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SDD-H and TRC participated in the experimental design
and interpretation of the data. ME and BJ collected, ana-
lyzed and interpreted electrophysiological data. LT identi-
fied the M1627K mutation, made the mutant M1627K
construct and established the stable cell lines. TZF and ML
collected and interpreted clinical data and confirmed a
diagnosis of PEPD. SGW conceived the project, partici-
pated in the experimental design and interpretation. All
authors participated in writing of the manuscript.
Acknowledgements
We thank Dr. Fuki Hisama for helpful discussions, and Emmanuella Eastman 
and Bart Toftness for excellent technical assistance. This work was sup-
ported by the Medical Research Service and Rehabilitation Research Serv-
ice, Dept. of Veterans Affairs and by a grant from the Erythromelalgia 
Association (SDH and SGW); TRC was supported by research grant 
NS053422 from the National Institute of Health. The Center for Neuro-
science and Regeneration Research is a Collaboration of the Paralyzed Vet-
erans of America, and the United Spinal Association with Yale University.
References
1. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG: From genes to
pain: Nav1.7 and human pain disorders.  Trends Neurosci 2007,
30(11):555-563.
2. Waxman SG: Channel, neuronal and clinical function in
sodium channelopathies: from genotype to phenotype.  Nat
Neurosci 2007, 10(4):405-409.
3. Black JA, Dib-Hajj S, McNabola K, Jeste S, Rizzo MA, Kocsis JD, Wax-
man SG: Spinal sensory neurons express multiple sodium
channel alpha-subunit mRNAs.  Mol Brain Res 1996, 43(1–
2):117-131.
4. Felts PA, Yokoyama S, Dib-Hajj S, Black JA, Waxman SG: Sodium
channel alpha-subunit mRNAs I, II, III, NaG, Na6 and HNE
(PN1) – different expression patterns in developing rat nerv-
ous system.  Mol Brain Res 1997, 45(1):71-82.
5. Sangameswaran L, Fish LM, Koch BD, Rabert DK, Delgado SG, Ilnicka
M, Jakeman LB, Novakovic S, Wong K, Sze P, et al.: A novel tetro-
dotoxin-sensitive, voltage-gated sodium channel expressed
in rat and human dorsal root ganglia.  J Biol Chem 1997,
272(23):14805-14809.
6. Toledo-Aral JJ, Moss BL, He ZJ, Koszowski AG, Whisenand T, Levin-
son SR, Wolf JJ, Silossantiago I, Halegoua S, Mandel G: Identification
of PN1, a predominant voltage-dependent sodium channel
expressed principally in peripheral neurons.  Proc Natl Acad Sci
(USA) 1997, 94(4):1527-1532.
7. Djouhri L, Newton R, Levinson SR, Berry CM, Carruthers B, Lawson
SN: Sensory and electrophysiological properties of guinea-
pig sensory neurones expressing Nav1.7 (PN1) Na+ channel
alpha-subunit protein.  J Physiol (Lond) 2003, 546(Pt 2):565-576.
8. Nassar MA, Stirling LC, Forlani G, Baker MD, Matthews EA, Dicken-
son AH, Wood JN: Nociceptor-specific gene deletion reveals a
major role for Nav1.7 (PN1) in acute and inflammatory pain.
Proc Natl Acad Sci USA 2004, 101(34):12706-12711.
9. Ahmad S, Dahllund L, Eriksson AB, Hellgren D, Karlsson U, Lund PE,
Meijer IA, Meury L, Mills T, Moody A, et al.: A stop codon mutation
in SCN9A causes lack of pain sensation.  Hum Mol Genet 2007,
16(17):2114-2121.
10. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K,
Karbani G, Jafri H, Mannan J, Raashid Y, et al.: An SCN9A chan-
nelopathy causes congenital inability to experience pain.
Nature 2006, 444(7121):894-898.
11. Goldberg Y, Macfarlane J, Macdonald M, Thompson J, Dube MP, Mat-
tice M, Fraser R, Young C, Hossain S, Pape T, et al.: Loss-of-function
mutations in the Nav1.7 gene underlie congenital indiffer-
ence to pain in multiple human populations.  Clin Genet 2007,
71(4):311-319.
12. Yang Y, Wang Y, Li S, Xu Z, Li H, Ma L, Fan J, Bu D, Liu B, Fan Z, et
al.: Mutations in SCN9A, encoding a sodium channel alpha
subunit, in patients with primary erythermalgia.  J Med Genet
2004, 41(3):171-174.
13. Dib-Hajj SD, Rush AM, Cummins TR, Hisama FM, Novella S, Tyrrell
L, Marshall L, Waxman SG: Gain-of-function mutation in Nav1.7
in familial erythromelalgia induces bursting of sensory neu-
rons.  Brain 2005, 128(Pt 8):1847-1854.Molecular Pain 2008, 4:37 http://www.molecularpain.com/content/4/1/37
Page 14 of 14
(page number not for citation purposes)
14. Drenth JP, Te Morsche RH, Guillet G, Taieb A, Kirby RL, Jansen JB:
SCN9A mutations define primary erythermalgia as a neuro-
pathic disorder of voltage gated sodium channels.  J Invest Der-
matol 2005, 124(6):1333-1338.
15. Michiels JJ, te Morsche RH, Jansen JB, Drenth JP: Autosomal dom-
inant erythermalgia associated with a novel mutation in the
voltage-gated sodium channel alpha subunit Nav1.7.  Arch
Neurol 2005, 62(10):1587-1590.
16. Han C, Rush AM, Dib-Hajj SD, Li S, Xu Z, Wang Y, Tyrrell L, Wang
X, Yang Y, Waxman SG: Sporadic onset of erythermalgia: a
gain-of-function mutation in Nav1.7.  Ann Neurol 2006,
59:553-558.
17. Harty TP, Dib-Hajj SD, Tyrrell L, Blackman R, Hisama FM, Rose JB,
Waxman SG: NaV1.7 mutant A863P in erythromelalgia:
effects of altered activation and steady-state inactivation on
excitability of nociceptive dorsal root ganglion neurons.  J
Neurosci 2006, 26(48):12566-12575.
18. Lee MJ, Yu HS, Hsieh ST, Stephenson DA, Lu CJ, Yang CC: Charac-
terization of a familial case with primary erythromelalgia
from Taiwan.  J Neurol 2007, 254(2):210-214.
19. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abraham-
sen B, Ostman J, Klugbauer N, Wood JN, Gardiner RM, et al.:
SCN9A mutations in paroxysmal extreme pain disorder:
allelic variants underlie distinct channel defects and pheno-
types.  Neuron 2006, 52(5):767-774.
20. Fertleman CR, Ferrie CD, Aicardi J, Bednarek NA, Eeg-Olofsson O,
Elmslie FV, Griesemer DA, Goutieres F, Kirkpatrick M, Malmros IN,
et al.: Paroxysmal extreme pain disorder (previously familial
rectal pain syndrome).  Neurology 2007, 69(6):586-595.
21. Choi JS, Dib-Hajj SD, Waxman SG: Inherited erythermalgia.
Limb pain from an S4 charge-neutral Na channelopathy.
Neurology 2006, 67(9):1563-1567.
22. Cummins TR, Dib-Hajj SD, Waxman SG: Electrophysiological
properties of mutant Nav1.7 sodium channels in a painful
inherited neuropathy.  J Neurosci 2004, 24(38):8232-8236.
23. Lampert A, Dib-Hajj SD, Tyrrell L, Waxman SG: Size matters:
Erythromelalgia mutation S241T in Nav1.7 alters channel
gating.  J Biol Chem 2006, 281(47):36029-36035.
24. Sheets PL, Jackson Ii JO, Waxman SG, Dib-Hajj S, Cummins TR: A
Nav1.7 channel mutation associated with hereditary eryth-
romelalgia contributes to neuronal hyperexcitability and dis-
plays reduced lidocaine sensitivity.  J Physiol (Lond) 2007,
581:1019-1031.
25. Cheng X, Dib-Hajj SD, Tyrrell L, Waxman SG: Mutation I136V
alters electrophysiological properties of the NaV1.7 channel
in a family with onset of erythromelalgia in the second dec-
ade.  Mol Pain 2008, 4(1):1.
26. Catterall WA, Yu FH: Painful channels.  Neuron 2006,
52(5):743-744.
27. Klugbauer N, Lacinova L, Flockerzi V, Hofmann F: Structure and
functional expression of a new member of the tetrodotoxin-
sensitive voltage-activated sodium channel family from
human neuroendocrine cells.  EMBO J 1995, 14(6):1084-1090.
28. Cummins TR, Howe JR, Waxman SG: Slow closed-state inactiva-
tion: a novel mechanism underlying ramp currents in cells
expressing the hNE/PN1 sodium channel.  J Neurosci 1998,
18(23):9607-9619.
29. Jarecki BW, Sheets PL, Jackson Ii JO, Cummins TR: Paroxysmal
Extreme Pain Disorder mutations within the D3/S4–S5
linker of Nav1.7 cause moderate destabilization of fast-inac-
tivation.  J Physiol (Lond) 2008, 586(Pt 17):4137-4153.
30. Drenth JP, Te Morsche RH, Mansour S, Mortimer PS: Primary ery-
thermalgia as a sodium channelopathy: screening for
SCN9A mutations: exclusion of a causal role of SCN10A and
SCN11A.  Arch Dermatol 2008, 144(3):320-324.
31. Burns TM, Te Morsche RH, Jansen JB, JP HD: Genetic heterogene-
ity and exclusion of a modifying locus at 2q in a family with
autosomal dominant primary erythermalgia.  Br J Dermatol
2005, 153(1):174-177.
32. Ragsdale DS, Avoli M: Sodium channels as molecular targets for
antiepileptic drugs.  Brain Res Rev 1998, 26(1):16-28.
33. Rush AM, Elliott JR: Phenytoin and Carbamazepine – Differen-
tial Inhibition Of Sodium Currents In Small Cells From
Adult Rat Dorsal Root Ganglia.  Neuroscience Letters 1997,
226(2):95-98.
34. Sheets PL, Heers C, Stoehr T, Cummins TR: Differential block of
sensory neuronal voltage-gated sodium channels by lacosa-
mide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropana-
mide], lidocaine, and carbamazepine.  J Pharmacol Exp Ther
2008, 326(1):89-99.
35. Herzog RI, Cummins TR, Ghassemi F, Dib-Hajj SD, Waxman SG: Dis-
tinct repriming and closed-state inactivation kinetics of
Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory
neurons.  J Physiol (Lond) 2003, 551(Pt 3):741-750.
36. Rush AM, Cummins TR, Waxman SG: Multiple sodium channels
and their roles in electrogenesis within dorsal root ganglion
neurons.  J Physiol (Lond) 2007, 579(Pt 1):1-14.
37. Cummins TR, Sheets PL, Waxman SG: The roles of sodium chan-
nels in nociception: Implications for mechanisms of pain.  Pain
2007.
38. Mitrovic N, Lerche H, Heine R, Fleischhauer R, Pika-Hartlaub U, Hart-
laub U, George AL Jr, Lehmann-Horn F: Role in fast inactivation
of conserved amino acids in the IV/S4–S5 loop of the human
muscle Na+ channel.  Neuroscience Letters 1996, 214(1):9-12.
39. Claes L, Ceulemans B, Audenaert D, Smets K, Lofgren A, Del-Favero
J, Ala-Mello S, Basel-Vanagaite L, Plecko B, Raskin S, et al.: De novo
SCN1A mutations are a major cause of severe myoclonic
epilepsy of infancy.  Hum Mutat 2003, 21(6):615-621.
40. Nabbout R, Gennaro E, Dalla Bernardina B, Dulac O, Madia F, Bertini
E, Capovilla G, Chiron C, Cristofori G, Elia M, et al.: Spectrum of
SCN1A mutations in severe myoclonic epilepsy of infancy.
Neurology 2003, 60(12):1961-1967.
41. Fleischhauer R, Mitrovic N, Deymeer F, Lehmann-Horn F, Lerche H:
Effects of temperature and mexiletine on the F1473S Na+
channel mutation causing paramyotonia congenita.  Pflugers
Arch 1998, 436(5):757-765.
42. Rossignol E, Mathieu J, Thiffault I, Tetreault M, Dicaire MJ, Chrestian
N, Dupre N, Puymirat J, Brais B: A novel founder SCN4A muta-
tion causes painful cold-induced myotonia in French-Canadi-
ans.  Neurology 2007, 69(20):1937-1941.
43. Schoser BG, Schroder JM, Grimm T, Sternberg D, Kress W: A large
german kindred with cold-aggravated myotonia and a heter-
ozygous A1481D mutation in the SCN4A gene.  Muscle Nerve
2007, 35:599-606.
44. Ruan Y, Liu N, Bloise R, Napolitano C, Priori SG: Gating properties
of SCN5A mutations and the response to mexiletine in long-
QT syndrome type 3 patients.  Circulation 2007,
116(10):1137-1144.
45. Smith MR, Goldin AL: Interaction between the sodium channel
inactivation linker and domain III S4–S5.  Biophys J 1997,
73(4):1885-1895.
46. McPhee JC, Ragsdale DS, Scheuer T, Catterall WA: A critical role
for the S4–S5 intracellular loop in domain IV of the sodium
channel alpha-subunit in fast inactivation.  J Biol Chem 1998,
273(2):1121-1129.
47. Lerche H, Peter W, Fleischhauer R, Pikahartlaub U, Malina T, Mitrovic
N, Lehmann-horn F: Role in fast inactivation of the IV/S4–S5
loop of the human muscle Na+ channel probed by cysteine
mutagenesis.  J Physiol (Lond) 1997, 505(2):345-352.
48. Miyamoto K, Nakagawa T, Kuroda Y: Solution structures of the
cytoplasmic linkers between segments S4 and S5 (S4–S5) in
domains III and IV of human brain sodium channels in SDS
micelles.  J Pept Res 2001, 58(3):193-203.
49. Kellenberger S, Scheuer T, Catterall WA: Movement of the Na+
channel inactivation gate during inactivation.  J Biol Chem 1996,
271(48):30971-30979.
50. Filatov GN, Nguyen TP, Kraner SD, Barchi RL: Inactivation and
secondary structure in the D4/S4–5 region of the SkM1
sodium channel.  J Gen Physiol 1998, 111(6):703-715.
51. Ahern CA, Zhang JF, Wookalis MJ, Horn R: Modulation of the car-
diac sodium channel NaV1.5 by Fyn, a Src family tyrosine
kinase.  Circ Res 2005, 96:991-998.
52. Rizzo MA, Kocsis JD, Waxman SG: Slow sodium conductances of
dorsal root ganglion neurons: intraneuronal homogeneity
and interneuronal heterogeneity.  J Neurophysiol 1994,
72(6):2796-2815.